Table 1.
Species | Transplant | Tolerance regimen | Mechanism of action | Ref. |
---|---|---|---|---|
(a) | ||||
Mice | Heart | Anti-LFA-1/ICAM-1 or anti-B7-1/B7-2 | IFN-γ production? | [33] |
Anti-CD154 mAb | iNKT cells require CXCL16/CXCR6 interactions to traffic to allograft | [38] | ||
Anti-CD154 mAb | IL-10 production | [41] | ||
Mice | Skin | None | IL-10 production | [37] |
Mice | Heart | Anti-CD4, CD8, CD154 mAb | Not determined | * |
Mice | Islet (rat xenograft) | Anti-CD4 mAb | IFN-γ production but the dose of CD4 is critical for tolerance induction | [42] |
Mice | Cornea | None | Enhanced regulatory T cell function | [43] |
Mice | Bone marrow | None | Prevent GVHD. IL-4-dependent | [44,45] |
(b) | ||||
Mice | Islet | None | IFN-γ production promotes PMN recruitment to graft | [46] |
None | Islet destruction only found when islets injected into portal vein | [34] | ||
Rapamycin | Not determined | [34] | ||
Mice | Skin | Anti-CD4, CD8, CD154 mAb | Not determined | * |
Mice | Skin | None | Induction of a Th17 response | ** |
GVHD: graft-versus-host disease; mAb: monoclonal antibody; Th: T helper; IFN: interferon; PMN: polymorphonuclear; IL: interleukin; LFA: leucocyte function antigen; ICAM: intercellular adhesion molecule.
Jukes J-P, Zhao Z & Jones ND, unpublished observations
Janes SE & Jones ND, manuscript in preparation.